Er Therapeutics Stock Price History
PNGM Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in PNGM Stock, it is important to understand the factors that can impact its price. As of today, the current price of Er Therapeutics stands at 0.0001, as last reported on the 27th of February, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Er Therapeutics, which you can use to evaluate the volatility of the firm.
PNGM Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
PNGM |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
PNGM |
Based on monthly moving average Er Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Er Therapeutics by adding Er Therapeutics to a well-diversified portfolio.
Er Therapeutics Stock Price History Chart
There are several ways to analyze PNGM Stock price data. The simplest method is using a basic PNGM candlestick price chart, which shows Er Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 3, 2024 | 1.0E-4 |
Lowest Price | December 3, 2024 | 1.0E-4 |
Er Therapeutics February 27, 2025 Stock Price Synopsis
Various analyses of Er Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell PNGM Stock. It can be used to describe the percentage change in the price of Er Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of PNGM Stock.Er Therapeutics Price Rate Of Daily Change | 1.00 |
Er Therapeutics February 27, 2025 Stock Price Analysis
PNGM Stock Price History Data
The price series of Er Therapeutics for the period between Fri, Nov 29, 2024 and Thu, Feb 27, 2025 has a statistical range of 0.0 with a coefficient of variation of 0.0. The price distribution for the period has arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company completed stock split (3:1) on 13th of April 2009.Open | High | Low | Close | Volume | ||
02/27/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | ||
02/26/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/25/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/24/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/21/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/20/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/19/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/18/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/14/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/13/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/12/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/11/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/10/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/07/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/06/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/05/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/04/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
02/03/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/31/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/30/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/29/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/28/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/27/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/24/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/23/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/22/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/21/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/20/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,200 | |
01/17/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/16/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/15/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/14/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/13/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/10/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/09/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,200 | |
01/08/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/07/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/06/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/03/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
01/02/2025 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/31/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/30/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/27/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/26/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/25/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,200 | |
12/24/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/23/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/20/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/19/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/18/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/17/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/16/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/13/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/12/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/11/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/10/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/09/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/06/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/05/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/04/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
12/03/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
About Er Therapeutics Stock history
Er Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PNGM is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Er Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Er Therapeutics stock prices may prove useful in developing a viable investing in Er Therapeutics
Pengram Corporation, an exploration stage mining company, engages in the acquisition, exploration, and development of natural resource properties, primarily gold. Pengram Corporation was founded in 2006 and is based in Bellingham, Washington. Pengram Corp operates under Other Industrial Metals Mining classification in the United States and is traded on OTC Exchange.
Er Therapeutics Stock Technical Analysis
Er Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Er Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Diversified Metals & Mining space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Er Therapeutics. If investors know PNGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Er Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Er Therapeutics is measured differently than its book value, which is the value of PNGM that is recorded on the company's balance sheet. Investors also form their own opinion of Er Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Er Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Er Therapeutics' market value can be influenced by many factors that don't directly affect Er Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Er Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Er Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Er Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.